US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sable Offshore Corp.

4.92

0.0000

Pre-market: 5.060.1437+2.92%05:31 EDT

Volume:6.98M

Turnover:34.55M

Market Cap:944.64M

PE:-1.46

High:5.12

Open:5.12

Low:4.82

Close:4.92

52wk High:24.96

52wk Low:2.88

Shares:192.00M

Float Shares:137.00M

Volume Ratio:1.22

T/O Rate:5.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.3799

EPS(LYR):-4.1777

ROE:-103.21%

ROA:-14.02%

PB:2.39

PE(LYR):-1.18

Loading ...

Overview Company News Filings

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

District court denies California parks department bid to block Sable Offshore pipeline

Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients

Sable Offshore Corp put volume heavy and directionally bearish

Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress

How Investors Are Reacting To Sable Offshore (SOC) Deeper Losses And High‑Risk Offshore Restart Strategy

Simply Wall St.

GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline

MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control

Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results

Emerging Growth Status at Sable Offshore Corp. Raises Transparency and Valuation Concerns

Press Release: IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights

Sable Offshore (SOC) Receives a Rating Update from a Top Analyst

Sable Offshore Corp reports results for the quarter ended March 31 - Earnings Summary

Sable Offshore Q1 net loss widens 80% to $197.03 million; revenue swings to $1.27 million

Sable Offshore Corp - Reports Q1 2026 Net Loss of $197.0 Mln

THOMSON REUTERS

Press Release: Sable Offshore Corp. Reports First Quarter 2026 Financial Results

Assessing Sable Offshore (SOC) Valuation After Upgraded Earnings Forecasts And Positive Analyst Rating

Simply Wall St.

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

Sable Offshore Corp call volume above normal and directionally bullish

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/SOC/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOC\",,,,,undefined,":{"symbol":"SOC","market":"US","secType":"STK","nameCN":"Sable Offshore Corp.","latestPrice":4.92,"timestamp":1789070400000,"preClose":4.92,"halted":0,"volume":6983428,"hourTrading":{"tag":"盘前","latestPrice":5.0637,"preClose":4.92,"latestTime":"05:31 EDT","volume":260,"amount":1286.66356,"timestamp":1789119081495,"change":0.1437,"changeRate":0.029207,"amplitude":0.049533},"delay":0,"changeRate":0,"floatShares":137000000,"shares":192000000,"eps":-3.379911,"marketStatus":"Pre-Mkt","change":0,"latestTime":"09-11 05:31:38 EDT","open":5.12,"high":5.12,"low":4.82,"amount":34553258.707260795,"amplitude":0.060976,"askPrice":5.53,"askSize":100,"bidPrice":4.82,"bidSize":13,"shortable":3,"etf":0,"ttmEps":-3.379911,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":4.92,"preHourTrading":{"tag":"盘前","latestPrice":5.0637,"preClose":4.92,"latestTime":"05:31 EDT","volume":260,"amount":1286.66356,"timestamp":1789119081495,"change":0.1437,"changeRate":0.029207,"amplitude":0.049533},"postHourTrading":{"tag":"盘后","latestPrice":4.95,"preClose":4.92,"latestTime":"19:53 EDT","volume":268588,"amount":1321574.7027,"timestamp":1789084411698,"change":0.03,"changeRate":0.006098,"amplitude":0.007602},"volumeRatio":1.221547626132677,"optionData":{"bulkOrders":[{"symbol":"SOC","call":true,"expireDate":1799989200000,"strike":"7.5","timestamp":1789048020483,"price":0.6,"volume":1999,"amount":119940,"type":"+"}]},"impliedVol":1.2372,"impliedVolPercentile":0.264},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOC\",,,,,undefined,":{"symbol":"SOC","floatShares":137000000,"roa":"-14.02%","roe":"-103.21%","lyrEps":-4.177665,"volumeRatio":1.221547626132677,"shares":192000000,"dividePrice":0,"high":5.12,"amplitude":0.060976,"preClose":4.92,"low":4.82,"week52Low":2.88,"pbRate":"2.39","psRate":"6.83","week52High":24.96,"institutionHeld":0,"latestPrice":4.92,"committee":-0.769912,"eps":-3.379911,"divideRate":0,"volume":6983428,"delay":0,"ttmEps":-3.379911,"open":5.12,"prevYearClose":9.02,"prevWeekClose":4.74,"prevMonthClose":4.83,"prevQuarterClose":3.08,"fiveDayClose":4.75,"twentyDayClose":4.38,"sixtyDayClose":10.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SOC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"SOC","fiscalQuarterEnding":"2026/06","expectedEps":0.21,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2026-05-06","symbol":"SOC","fiscalQuarterEnding":"2026/03","expectedEps":-0.64,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-1.37},{"market":"US","date":"2026-02-27","symbol":"SOC","fiscalQuarterEnding":"2025/12","expectedEps":-0.59,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772168400000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2025-11-13","symbol":"SOC","fiscalQuarterEnding":"2025/09","expectedEps":-0.9,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-1.11},{"market":"US","date":"2025-08-12","symbol":"SOC","fiscalQuarterEnding":"2025/06","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-1.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SOC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SOC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":5,"updateTime":1772769600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SOC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SOC","date":"2026-09-10","current":-1.45566,"percent":0.882825,"low":-49.514744,"twenty":-5.291374,"median":-4.097563,"eighty":-2.87681,"high":-0.945554,"avg":-6.710238,"sd":9.640693,"marketCap":943998294},"quantilePoints":[{"date":"2024-02-16","current":-10.965511,"twenty":-10.965511,"median":-10.965511,"eighty":-10.965511,"marketCap":164955978},{"date":"2024-02-23","current":-47.994905,"twenty":-48.050899,"median":-47.994905,"eighty":-40.589026,"marketCap":721995228},{"date":"2024-03-01","current":-48.874812,"twenty":-48.810818,"median":-47.994905,"eighty":-47.810925,"marketCap":735231807},{"date":"2024-03-08","current":-48.51485,"twenty":-48.842815,"median":-48.51485,"eighty":-47.970908,"marketCap":729816842},{"date":"2024-03-15","current":-46.995011,"twenty":-48.834816,"median":-48.13489,"eighty":-47.810925,"marketCap":706953660},{"date":"2024-03-22","current":-44.715253,"twenty":-48.802819,"median":-47.994905,"eighty":-46.491065,"marketCap":672658887},{"date":"2024-03-28","current":-44.475279,"twenty":-48.79482,"median":-47.954909,"eighty":-44.667258,"marketCap":669048911},{"date":"2024-04-05","current":-20.510023,"twenty":-48.626838,"median":-47.554952,"eighty":-43.603371,"marketCap":660023970},{"date":"2024-04-12","current":-20.47263,"twenty":-48.442858,"median":-46.715041,"eighty":-20.502545,"marketCap":658820645},{"date":"2024-04-19","current":-19.182574,"twenty":-48.32287,"median":-44.795244,"eighty":-20.47263,"marketCap":617305919},{"date":"2024-04-26","current":-19.5752,"twenty":-48.106893,"median":-44.595266,"eighty":-20.42028,"marketCap":629940836},{"date":"2024-05-03","current":-19.593896,"twenty":-47.994905,"median":-43.535379,"eighty":-19.762164,"marketCap":630542499},{"date":"2024-05-10","current":-20.659595,"twenty":-47.994905,"median":-20.566113,"eighty":-19.777121,"marketCap":664837272},{"date":"2024-05-17","current":-26.212445,"twenty":-47.994905,"median":-20.911997,"eighty":-19.833211,"marketCap":843531091},{"date":"2024-05-24","current":-4.001469,"twenty":-47.970907,"median":-20.566113,"eighty":-19.605114,"marketCap":803821353},{"date":"2024-05-31","current":-4.492667,"twenty":-47.922913,"median":-20.510023,"eighty":-19.496675,"marketCap":902494035},{"date":"2024-06-07","current":-4.456726,"twenty":-47.746932,"median":-20.481978,"eighty":-19.242403,"marketCap":895274082},{"date":"2024-06-14","current":-4.444746,"twenty":-47.554952,"median":-20.47263,"eighty":-4.563951,"marketCap":892867431},{"date":"2024-06-21","current":-4.336922,"twenty":-47.554952,"median":-20.47263,"eighty":-4.498658,"marketCap":871207575},{"date":"2024-06-28","current":-4.375858,"twenty":-47.330976,"median":-20.453933,"eighty":-4.49087,"marketCap":879029190},{"date":"2024-07-05","current":-4.729281,"twenty":-46.939017,"median":-20.360451,"eighty":-4.493865,"marketCap":950025387},{"date":"2024-07-12","current":-4.666384,"twenty":-46.491065,"median":-20.080004,"eighty":-4.499856,"marketCap":937390471},{"date":"2024-07-15","current":-4.792179,"twenty":-46.267089,"median":-20.014567,"eighty":-4.501054,"marketCap":962660304},{"date":"2024-08-02","current":-4.753242,"twenty":-46.043112,"median":-19.949129,"eighty":-4.502252,"marketCap":954838689},{"date":"2024-08-09","current":-4.193156,"twenty":-45.163206,"median":-19.771513,"eighty":-4.476494,"marketCap":842327766},{"date":"2024-08-16","current":-2.818059,"twenty":-44.779246,"median":-19.612593,"eighty":-4.43576,"marketCap":969439268},{"date":"2024-08-23","current":-2.836909,"twenty":-44.643261,"median":-19.584548,"eighty":-4.379452,"marketCap":975923811},{"date":"2024-08-30","current":-3.106462,"twenty":-44.595266,"median":-19.425628,"eighty":-4.335724,"marketCap":1068652785},{"date":"2024-09-06","current":-4.073462,"twenty":-44.547271,"median":-19.332146,"eighty":-4.230058,"marketCap":1401309871},{"date":"2024-09-13","current":-3.988638,"twenty":-44.235304,"median":-7.878845,"eighty":-4.193156,"marketCap":1372129425},{"date":"2024-09-20","current":-5.33452,"twenty":-43.603371,"median":-4.857618,"eighty":-4.199566,"marketCap":1835125838},{"date":"2024-09-27","current":-5.343032,"twenty":-36.402227,"median":-4.781696,"eighty":-4.199566,"marketCap":1838054195},{"date":"2024-10-04","current":-5.755604,"twenty":-24.956043,"median":-4.880237,"eighty":-4.209959,"marketCap":1979982860},{"date":"2024-10-11","current":-4.598218,"twenty":-22.592809,"median":-4.868927,"eighty":-4.213365,"marketCap":1581830780},{"date":"2024-10-18","current":-4.725113,"twenty":-21.590679,"median":-4.792179,"eighty":-4.229539,"marketCap":1625484098},{"date":"2024-10-25","current":-4.888949,"twenty":-20.962478,"median":-4.790222,"eighty":-4.249285,"marketCap":1681845104},{"date":"2024-10-31","current":-4.998173,"twenty":-20.648377,"median":-4.810961,"eighty":-4.266836,"marketCap":1719419108},{"date":"2024-11-08","current":-5.61315,"twenty":-20.596027,"median":-4.880237,"eighty":-4.334526,"marketCap":1930977089},{"date":"2024-11-15","current":-3.401519,"twenty":-20.554895,"median":-4.900821,"eighty":-4.334526,"marketCap":2003855918},{"date":"2024-11-22","current":-3.557753,"twenty":-20.510023,"median":-4.857618,"eighty":-4.212246,"marketCap":2051078846},{"date":"2024-11-29","current":-3.628847,"twenty":-20.510023,"median":-4.805844,"eighty":-4.193156,"marketCap":2092064783},{"date":"2024-12-06","current":-2.944188,"twenty":-20.491327,"median":-4.779739,"eighty":-4.113047,"marketCap":1697352390},{"date":"2024-12-13","current":-3.083283,"twenty":-20.491327,"median":-4.753242,"eighty":-3.988638,"marketCap":1777542266},{"date":"2024-12-20","current":-3.440295,"twenty":-20.47263,"median":-4.727197,"eighty":-3.815772,"marketCap":1983362950},{"date":"2024-12-27","current":-3.676757,"twenty":-20.47263,"median":-4.697136,"eighty":-3.712613,"marketCap":2119685740},{"date":"2025-01-03","current":-3.597937,"twenty":-20.47263,"median":-4.668442,"eighty":-3.657593,"marketCap":2074244810},{"date":"2025-01-10","current":-3.51757,"twenty":-20.47263,"median":-4.649598,"eighty":-3.630083,"marketCap":2027912881},{"date":"2025-01-17","current":-3.811216,"twenty":-20.47263,"median":-4.615467,"eighty":-3.610301,"marketCap":2197202621},{"date":"2025-01-24","current":-4.367598,"twenty":-20.465151,"median":-4.609477,"eighty":-3.628847,"marketCap":2517962128},{"date":"2025-01-31","current":-3.859127,"twenty":-20.427758,"median":-4.5959,"eighty":-3.629465,"marketCap":2224823579},{"date":"2025-02-07","current":-3.491297,"twenty":-20.382887,"median":-4.55257,"eighty":-3.628847,"marketCap":2012765905},{"date":"2025-02-14","current":-4.733883,"twenty":-20.293145,"median":-4.531604,"eighty":-3.604119,"marketCap":2729128803},{"date":"2025-02-21","current":-4.54224,"twenty":-20.173487,"median":-4.551073,"eighty":-3.628847,"marketCap":2618644973},{"date":"2025-02-28","current":-4.291868,"twenty":-20.080004,"median":-4.534513,"eighty":-3.628847,"marketCap":2474303195},{"date":"2025-03-07","current":-3.568572,"twenty":-19.949129,"median":-4.506443,"eighty":-3.628847,"marketCap":2057315836},{"date":"2025-03-14","current":-3.656666,"twenty":-19.855647,"median":-4.498658,"eighty":-3.616483,"marketCap":2108102758},{"date":"2025-03-21","current":-3.688441,"twenty":-19.799557,"median":-4.493498,"eighty":-3.616483,"marketCap":2320276640},{"date":"2025-03-28","current":-3.714026,"twenty":-19.743468,"median":-4.48816,"eighty":-3.616483,"marketCap":2336371044},{"date":"2025-04-04","current":-3.081519,"twenty":-19.706075,"median":-4.44175,"eighty":-3.606002,"marketCap":1938481601},{"date":"2025-04-11","current":-2.477439,"twenty":-19.612593,"median":-4.43576,"eighty":-3.570468,"marketCap":1558474829},{"date":"2025-04-17","current":-2.787296,"twenty":-19.597635,"median":-4.41653,"eighty":-3.557444,"marketCap":1753395950},{"date":"2025-04-25","current":-2.787296,"twenty":-19.593896,"median":-4.401482,"eighty":-3.529934,"marketCap":1753395950},{"date":"2025-05-02","current":-2.841765,"twenty":-19.578939,"median":-4.381848,"eighty":-3.496243,"marketCap":1787660543},{"date":"2025-05-09","current":-2.978101,"twenty":-19.4705,"median":-4.366826,"eighty":-3.412757,"marketCap":1873425367},{"date":"2025-05-16","current":-4.5891,"twenty":-19.429367,"median":-4.367598,"eighty":-3.435349,"marketCap":2508938825},{"date":"2025-05-23","current":-5.794479,"twenty":-19.410671,"median":-4.383223,"eighty":-3.441532,"marketCap":3167939997},{"date":"2025-05-30","current":-4.998561,"twenty":-19.36206,"median":-4.401482,"eighty":-3.471515,"marketCap":2732798228},{"date":"2025-06-06","current":-4.217252,"twenty":-19.242403,"median":-4.399819,"eighty":-3.495006,"marketCap":2305643289},{"date":"2025-06-13","current":-4.171827,"twenty":-14.252336,"median":-4.392209,"eighty":-3.509534,"marketCap":2280808699},{"date":"2025-06-20","current":-4.088245,"twenty":-8.972656,"median":-4.378853,"eighty":-3.51757,"marketCap":2235113055},{"date":"2025-06-27","current":-4.050088,"twenty":-5.92305,"median":-4.367598,"eighty":-3.522516,"marketCap":2214251999},{"date":"2025-07-03","current":-4.22452,"twenty":-5.824946,"median":-4.351897,"eighty":-3.529934,"marketCap":2309616823},{"date":"2025-07-11","current":-3.961055,"twenty":-5.786704,"median":-4.335425,"eighty":-3.529934,"marketCap":2165576204},{"date":"2025-07-18","current":-5.149372,"twenty":-5.748008,"median":-4.320884,"eighty":-3.531789,"marketCap":2815249065},{"date":"2025-07-25","current":-5.207516,"twenty":-5.748008,"median":-4.342912,"eighty":-3.542607,"marketCap":2847037340},{"date":"2025-08-01","current":-5.572732,"twenty":-5.706632,"median":-4.366053,"eighty":-3.556517,"marketCap":3046707439},{"date":"2025-08-08","current":-5.274745,"twenty":-5.659883,"median":-4.371961,"eighty":-3.55868,"marketCap":2883792532},{"date":"2025-08-15","current":-5.817892,"twenty":-5.659883,"median":-4.384599,"eighty":-3.563626,"marketCap":2963325905},{"date":"2025-08-22","current":-5.313857,"twenty":-5.647035,"median":-4.404183,"eighty":-3.568951,"marketCap":2706597200},{"date":"2025-08-29","current":-5.477962,"twenty":-5.637377,"median":-4.41653,"eighty":-3.571634,"marketCap":2790183290},{"date":"2025-09-05","current":-4.489428,"twenty":-5.626437,"median":-4.43576,"eighty":-3.576299,"marketCap":2286676605},{"date":"2025-09-12","current":-4.522639,"twenty":-5.624483,"median":-4.43576,"eighty":-3.597937,"marketCap":2303592837},{"date":"2025-09-19","current":-4.700419,"twenty":-5.61315,"median":-4.43576,"eighty":-3.604581,"marketCap":2394144435},{"date":"2025-09-26","current":-3.936552,"twenty":-5.572732,"median":-4.437257,"eighty":-3.606002,"marketCap":2005071087},{"date":"2025-10-03","current":-3.821288,"twenty":-5.563921,"median":-4.426775,"eighty":-3.606002,"marketCap":1946361810},{"date":"2025-10-10","current":-3.838871,"twenty":-5.549318,"median":-4.409354,"eighty":-3.616483,"marketCap":1955317462},{"date":"2025-10-17","current":-2.563155,"twenty":-5.548292,"median":-4.399819,"eighty":-3.597937,"marketCap":1305535120},{"date":"2025-10-24","current":-2.738981,"twenty":-5.547051,"median":-4.381913,"eighty":-3.568572,"marketCap":1395091645},{"date":"2025-10-31","current":-2.5065,"twenty":-5.540478,"median":-4.368063,"eighty":-3.539207,"marketCap":1276678017},{"date":"2025-11-07","current":-0.945554,"twenty":-5.532419,"median":-4.358975,"eighty":-3.51757,"marketCap":481615090},{"date":"2025-11-14","current":-1.676313,"twenty":-5.527307,"median":-4.336922,"eighty":-3.455961,"marketCap":853824978},{"date":"2025-11-21","current":-1.695809,"twenty":-5.483699,"median":-4.317243,"eighty":-3.411027,"marketCap":617537250},{"date":"2025-11-28","current":-1.640078,"twenty":-5.482245,"median":-4.300534,"eighty":-3.376311,"marketCap":597242599},{"date":"2025-12-05","current":-2.030194,"twenty":-5.478746,"median":-4.251086,"eighty":-3.332419,"marketCap":739305159},{"date":"2025-12-12","current":-2.245155,"twenty":-5.477962,"median":-4.24482,"eighty":-3.219906,"marketCap":817584529},{"date":"2025-12-19","current":-3.284137,"twenty":-5.47383,"median":-4.22452,"eighty":-3.171377,"marketCap":1195934817},{"date":"2025-12-26","current":-3.925041,"twenty":-5.467025,"median":-4.216721,"eighty":-3.152831,"marketCap":1429323308},{"date":"2026-01-02","current":-3.590656,"twenty":-5.462381,"median":-4.209181,"eighty":-3.168286,"marketCap":1307555399},{"date":"2026-01-09","current":-3.71406,"twenty":-5.448387,"median":-4.203223,"eighty":-3.173483,"marketCap":1352493556},{"date":"2026-01-16","current":-4.609734,"twenty":-5.428691,"median":-4.209181,"eighty":-3.181181,"marketCap":1678657597},{"date":"2026-01-23","current":-4.936157,"twenty":-5.426739,"median":-4.211657,"eighty":-3.198578,"marketCap":1797526270},{"date":"2026-01-30","current":-3.980772,"twenty":-5.420626,"median":-4.203223,"eighty":-3.238143,"marketCap":1449617960},{"date":"2026-02-06","current":-2.917906,"twenty":-5.414621,"median":-4.193156,"eighty":-3.221758,"marketCap":1062569964},{"date":"2026-02-13","current":-3.280156,"twenty":-5.410172,"median":-4.184611,"eighty":-3.221758,"marketCap":1194485199},{"date":"2026-02-20","current":-3.554829,"twenty":-5.405568,"median":-4.172735,"eighty":-3.227015,"marketCap":1294508838},{"date":"2026-02-27","current":-3.148791,"twenty":-5.400288,"median":-4.164559,"eighty":-3.227015,"marketCap":1146647806},{"date":"2026-03-06","current":-4.972012,"twenty":-5.382234,"median":-4.145533,"eighty":-3.220444,"marketCap":2039330591},{"date":"2026-03-13","current":-6.264377,"twenty":-5.400288,"median":-4.164559,"eighty":-3.227015,"marketCap":2569409300},{"date":"2026-03-20","current":-6.15309,"twenty":-5.421921,"median":-4.179095,"eighty":-3.244329,"marketCap":2523763634},{"date":"2026-03-27","current":-6.433102,"twenty":-5.463177,"median":-4.187166,"eighty":-3.280156,"marketCap":2638614021},{"date":"2026-04-02","current":-5.277154,"twenty":-5.477962,"median":-4.193156,"eighty":-3.282154,"marketCap":2164488064},{"date":"2026-04-10","current":-4.674051,"twenty":-5.477962,"median":-4.210154,"eighty":-3.28384,"marketCap":1917117999},{"date":"2026-04-17","current":-5.158687,"twenty":-5.47383,"median":-4.216721,"eighty":-3.290506,"marketCap":2115897515},{"date":"2026-04-24","current":-5.119198,"twenty":-5.465101,"median":-4.22452,"eighty":-3.29567,"marketCap":2099700666},{"date":"2026-05-01","current":-5.151508,"twenty":-5.461584,"median":-4.247484,"eighty":-3.3114,"marketCap":2112952634},{"date":"2026-05-08","current":-3.796171,"twenty":-5.435588,"median":-4.249415,"eighty":-3.332419,"marketCap":1889141623},{"date":"2026-05-15","current":-4.265077,"twenty":-5.428193,"median":-4.248766,"eighty":-3.345401,"marketCap":2122490012},{"date":"2026-05-22","current":-4.519431,"twenty":-5.423126,"median":-4.258081,"eighty":-3.350038,"marketCap":2249067598},{"date":"2026-05-29","current":-4.556653,"twenty":-5.418036,"median":-4.265077,"eighty":-3.352043,"marketCap":2267591147},{"date":"2026-06-05","current":-4.199938,"twenty":-5.412972,"median":-4.251086,"eighty":-3.354661,"marketCap":2090073801},{"date":"2026-06-12","current":-3.635397,"twenty":-5.40787,"median":-4.248125,"eighty":-3.366619,"marketCap":1809133305},{"date":"2026-06-18","current":-3.179421,"twenty":-5.403456,"median":-4.232696,"eighty":-3.35158,"marketCap":1582219827},{"date":"2026-06-26","current":-2.354323,"twenty":-5.393066,"median":-4.217252,"eighty":-3.303981,"marketCap":1171614486},{"date":"2026-07-02","current":-1.364825,"twenty":-5.382177,"median":-4.211657,"eighty":-3.284907,"marketCap":679196804},{"date":"2026-07-10","current":-1.594795,"twenty":-5.380699,"median":-4.209212,"eighty":-3.230478,"marketCap":793640368},{"date":"2026-07-17","current":-1.594795,"twenty":-5.372119,"median":-4.197265,"eighty":-3.175342,"marketCap":793640368},{"date":"2026-07-24","current":-1.795108,"twenty":-5.35754,"median":-4.190161,"eighty":-3.151179,"marketCap":893324665},{"date":"2026-07-31","current":-1.725769,"twenty":-5.356634,"median":-4.184611,"eighty":-3.106462,"marketCap":858818562},{"date":"2026-08-07","current":-1.845186,"twenty":-5.343032,"median":-4.171827,"eighty":-3.083283,"marketCap":918245739},{"date":"2026-08-14","current":-1.782492,"twenty":-5.33452,"median":-4.158252,"eighty":-3.025387,"marketCap":773234375},{"date":"2026-08-21","current":-2.24249,"twenty":-5.313857,"median":-4.13367,"eighty":-2.944188,"marketCap":972778730},{"date":"2026-08-28","current":-2.061145,"twenty":-5.302,"median":-4.117478,"eighty":-2.910424,"marketCap":894112205},{"date":"2026-09-04","current":-2.087683,"twenty":-5.292367,"median":-4.109983,"eighty":-2.889689,"marketCap":905624379},{"date":"2026-09-10","current":-2.176144,"twenty":-5.291374,"median":-4.097563,"eighty":-2.87681,"marketCap":943998294}],"updateTime":1789119098335},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SOC\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640353809","title":"UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=2640353809","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640353809?lang=en_us&edition=fundamental","pubTime":"2026-06-01 13:30","pubTimestamp":1780291800,"startTime":"0","endTime":"0","summary":"Publication adds to previously reported findings from Phase 3 PHOENYCS GO study, demonstrating statistically significant improvement in disease activity at Week 48 with dapirolizumab pegol plus standa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304009/0/en/UCB-and-Biogen-Announce-Publication-in-The-Lancet-of-Positive-Dapirolizumab-Pegol-DZP-Phase-3-Study-Results-in-Systemic-Lupus-Erythematosus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU1066053197.SGD","BK4585","LU2236285917.USD","BK4588","LU0109394709.USD","BIIB","IE00BD4GTV84.USD","PEG","BK4533","LU2237443978.SGD","IE00B19Z9P08.USD","LU2237443549.SGD","LU0314104364.USD","SLE","IE00B894F039.SGD","LU2346227817.USD","BK4532","LU1366333091.USD","LU0786609619.USD","LU1935043536.SGD","APC","IE00BMG7P587.USD","LU0320765992.SGD","LU0889565916.HKD","IE00BD4GTW91.USD","LU1935043023.USD","LU1935042215.USD","LU0149725797.USD","LU2417539215.USD","LU1674673691.USD","LU1718418525.SGD","BK4214","IE00BMG7P694.USD","LU1366192091.USD","LU1935042991.SGD","BK4077","BK4211","LU0157215616.USD","IE00B19Z9Z06.USD","IFN","LU0882574139.USD","LU2083900584.USD","BK4213","LU1066051811.HKD","LU0170899867.USD","IE00BMG7P926.USD","BK4523","SOC","UCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639114896","title":"District court denies California parks department bid to block Sable Offshore pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2639114896","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639114896?lang=en_us&edition=fundamental","pubTime":"2026-05-29 05:41","pubTimestamp":1780004516,"startTime":"0","endTime":"0","summary":"NEW YORK, May 28  - A U.S. District Court on Thursday denied the California Department of Parks and Recreation's bid to stop oil producer Sable Offshore Corp SOC.N from moving oil on a long-disputed pipeline linked to the Santa Ynez offshore platform.The denial marks a setback for California's efforts to stop the Santa Ynez project, which Sable restarted in March after intervention from the federal government. For Sable, it marks a major win and sent the company's shares up nearly 12%.* The Department of Parks and Recreation had sought preliminary injunctive relief, citing irreparable harm to it from the use of a section of Sable's pipeline under the Gaviota State Park.* The U.S. District Court for the Central District of California said the department \"manifestly failed to demonstrate that it will suffer irreparable harm in the absence of preliminary injunctive relief.\"* Parks and Recreation and the California governor's office did not immediately respond to requests for comment.* Sev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nL1N42519Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698439","title":"Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698439","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698439?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969600,"startTime":"0","endTime":"0","summary":"SYDNEY, AUSTRALIA, May  28, 2026  (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company targeting cancer and autoimmune dise","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302799/0/en/Systemic-immune-activation-with-eftilagimod-alfa-associated-with-statistically-significant-increased-overall-survival-in-late-stage-cancer-patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","LU1935042991.SGD","BK4534","LU1804176565.USD","LU1935043023.USD","LU1496350171.SGD","BK4213","LU1935042488.USD","LU2236285917.USD","LU1066051811.HKD","LU1066053197.SGD","LU0314104364.USD","LU1935043536.SGD","LU2083900584.USD","LU0077335932.USD","LU0786609619.USD","LU1674673428.USD","LU1674673691.USD","ALC","BK4214","BK4198","LU1366192091.USD","LU2237443382.USD","BK4139","APC","IMMP","LU2456880835.USD","LU0053666078.USD","LU0157215616.USD","LU1066051225.USD","LU0882574139.USD","LU2237443978.SGD","LU2417539215.USD","LU0149725797.USD","LU1778281490.HKD","LU1366333091.USD","LU1935042215.USD","LU1066051498.USD","LU1718418525.SGD","SOC","LU2237443622.USD","LU0170899867.USD","LU2420271590.USD","LU2265009873.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638549517","title":"Sable Offshore Corp put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2638549517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638549517?lang=en_us&edition=fundamental","pubTime":"2026-05-27 00:09","pubTimestamp":1779811767,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Sable Offshore (SOC) Corp with 1,226 puts trading, or 3x expected. Most active are Jan-27 50 calls and 5/29 weekly 13 puts, w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sable-offshore-corp-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sable-offshore-corp-put-volume-heavy-and-directionally-bearish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637575363","title":"Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2637575363","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637575363?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397200,"startTime":"0","endTime":"0","summary":"Media ReleaseCOPENHAGEN, Denmark; May 21, 2026  Twenty-three abstracts will highlight the versatility and strength of Genmab’s portfolio and pipeline, including data from the comprehensive epcoritamab","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299787/0/en/Genmab-to-Highlight-Advances-Across-Its-Oncology-Portfolio-at-the-2026-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting-and-the-European-Hematology-Association-EHA-2026-Co.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFG","BK4117","CRC","LU0456854461.SGD","LU0266512127.USD","BK4213","SOC","BK4107","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635889728","title":"How Investors Are Reacting To Sable Offshore (SOC) Deeper Losses And High‑Risk Offshore Restart Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2635889728","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635889728?lang=en_us&edition=fundamental","pubTime":"2026-05-15 02:47","pubTimestamp":1778784462,"startTime":"0","endTime":"0","summary":"Sable Offshore Corp. has reported first-quarter 2026 results, generating US$1.27 million in revenue while recording a net loss of US$197.03 million and a basic loss per share from continuing operations of US$1.37, and it continues to advance refinancing discussions on its Senior Secured Term Loan.\nAlongside these weak financials, the company is restarting production at its Santa Ynez assets and preparing Platform Hondo to begin operations, highlighting a high‑spend, high‑risk push to turn...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/energy/nyse-soc/sable-offshore/news/how-investors-are-reacting-to-sable-offshore-soc-deeper-loss","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-soc/sable-offshore/news/how-investors-are-reacting-to-sable-offshore-soc-deeper-loss","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SOC","ISBC","BK4213","BK7061","SOC.AU","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635717053","title":"GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2635717053","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635717053?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:35","pubTimestamp":1778762100,"startTime":"0","endTime":"0","summary":"Phase 2a data show zero cough and 60% lower treatment-related diarrhea than placebo despite higher nintedanib use in the active arm – suggesting GRI-0621 may mitigate nintedanib-related GI-toxicities ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294952/0/en/GRI-Bio-Reports-First-Quarter-2026-Financial-Results-New-Data-Reinforcing-Differentiated-Profile-of-GRI-0621-in-Idiopathic-Pulmonary-Fibrosis-and-Highlights-Continued-Advancement-o.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","BK4007","SOC","BK4139","GRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635654627","title":"MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control","url":"https://stock-news.laohu8.com/highlight/detail?id=2635654627","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635654627?lang=en_us&edition=fundamental","pubTime":"2026-05-14 10:30","pubTimestamp":1778725800,"startTime":"0","endTime":"0","summary":"- Achieved statistical significance versus standard-of-care  control across all key efficacy endpoints in the 52-week study- Japan Phase 3 results strengthen CARTISTEM's global commercial prospects, with Japan biologics license application  scheduled for 2H 2026 SEOUL, South Korea and TOKYO, May 14, 2026 /PRNewswire/ -- MEDIPOST has met all primary and secondary efficacy endpoints in the Japan Phase 3 clinical trial of CARTISTEM, demonstrating clinical improvements in pain and function as well as cartilage regeneration. Based on the results, MEDIPOST is expected to accelerate preparations for its biologics license application  filing in Japan later this year.MEDIPOST CARTISTEM Japan Phase 3 Results Press Conference – Antonio Lee, Executive Vice President of Global Business Division at MEDIPOST","market":"us","thumbnail":"https://mma.prnewswire.com/media/2979923/final.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2979923/final.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/mediposts-cartistem-meets-all-primary-and-secondary-endpoints-in-japan-phase-3-trial-and-demonstrates-statistically-significant-efficacy-gains-versus-active-control-302771733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","BLA.AU","VAS.AU","SOC.AU","BK7061","SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218216","title":"Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218216?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"Enrollment completed in the PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis; topline data on track for the summer of 2026. Ongoing Phase 1 trial evaluating NBD1 stabilizer SION-451 in proprietary dual combinations with SION-2222 and with SION-109 in healthy volunteers is also on track for topline data in the summer of 2026. Maintained strong cash position with approximately $289.9 million in cash and cash equivalents, expected to fund operations into 2028. \"We entered 2026 with strong execution across our programs, highlighted by the recent completion of enrollment in our proof-of-concept Phase 2a trial of SION-719, an important milestone for Sionna,\" said Mike Cloonan, President and Chief Executive Officer of Sionna. \"With both of our clinical stage NBD1 stabilizer programs on track for topline readouts this summer, we remain focused on advancing these first-in-class product candidat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4181","PK","SION","SOC","BK4213","BK4139","CF","BK4585","BK4093","BK4218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633489704","title":"Emerging Growth Status at Sable Offshore Corp. Raises Transparency and Valuation Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2633489704","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633489704?lang=en_us&edition=fundamental","pubTime":"2026-05-08 14:01","pubTimestamp":1778220107,"startTime":"0","endTime":"0","summary":"Sable Offshore Corp. (SOC) has disclosed a new risk, in the Share Price & Shareholder Rights category. Sable Offshore Corp. is classified as an eme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/emerging-growth-status-at-sable-offshore-corp-raises-transparency-and-valuation-concerns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/emerging-growth-status-at-sable-offshore-corp-raises-transparency-and-valuation-concerns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633174191","title":"Press Release: IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2633174191","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633174191?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:30","pubTimestamp":1778185800,"startTime":"0","endTime":"0","summary":"-- Advancing next-generation <GAMMA> T cell engager platform with initial. -- Reported glioblastoma  data showing 97% improvement in. \"In the first quarter of 2026, we continued to advance our next-generation TCE platform and clinical programs,\" said William Ho, Chief Executive Officer and co-founder of IN8bio. \"Our encouraging GBM data positions us to engage the FDA on potential regulatory pathways forward, and we expect to deliver meaningful preclinical, regulatory and clinical milestones across our pipeline this year. As industry interest in novel TCEs accelerates, our next-generation platform is designed to address the key challenges in TCE development. We believe IN8bio is well positioned to create meaningful value for patients and shareholders in 2026 and beyond. We look forward to sharing further updates across our programs at our upcoming R&D Day in New York City on May 21, 2026.\". -- Median progression-free survival  for repeat dose patients was 13.0","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SBC","CRS","IE0031619046.USD","IE00B66KJ199.SGD","BK4209","BK4213","LU0154245673.USD","IE00B7SZL793.SGD","IE00B19Z4B17.USD","LU0963586101.USD","BK4139","BK4504","BK4196","INAB","BK4187","DRI","LU0154245756.USD","LU2065731478.USD","BK4588","BK4539","SOC","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633127581","title":"Sable Offshore (SOC) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2633127581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633127581?lang=en_us&edition=fundamental","pubTime":"2026-05-08 01:15","pubTimestamp":1778174138,"startTime":"0","endTime":"0","summary":"In a report released today, Leo Mariani from Roth MKM maintained a Buy rating on Sable Offshore, with a price target of $24.00. According to TipRan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sable-offshore-soc-receives-a-rating-update-from-a-top-analyst-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sable-offshore-soc-receives-a-rating-update-from-a-top-analyst-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633141719","title":"Sable Offshore Corp reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633141719","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633141719?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:00","pubTimestamp":1778155213,"startTime":"0","endTime":"0","summary":"Sable Offshore Corp reports results for the quarter ended March 31 - Earnings SummarySable Offshore Corp SOC.N reported a quarterly adjusted loss of $1.37 per share for the quarter ended March 31, low","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K1DR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633151413","title":"Sable Offshore Q1 net loss widens 80% to $197.03 million; revenue swings to $1.27 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633151413","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633151413?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:10","pubTimestamp":1778098205,"startTime":"0","endTime":"0","summary":"Sable Offshore posted a net loss of USD 197.03 million for the quarter ended March 31, 2026, widening 80%.Revenue swung to USD 1.27 million as oil sales began late in the quarter, with 13,380 barrels sold.Operating loss widened to USD 118.75 million as operating expenses climbed to USD 120.03 million, led by operations and maintenance expense of USD 68.03 million, up 98%.Interest expense rose to USD 34.67 million, up 65%, while total debt stood at USD 956.3 million with USD 52.2 million of unrestricted cash.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sable Offshore Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Secur","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL2ms3Nr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633157914","title":"Sable Offshore Corp - Reports Q1 2026 Net Loss of $197.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2633157914","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633157914?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:06","pubTimestamp":1778097961,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA9ZSLR4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SOC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633151966","title":"Press Release: Sable Offshore Corp. Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633151966","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633151966?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:06","pubTimestamp":1778097960,"startTime":"0","endTime":"0","summary":"Sable Offshore Corp.  today announced its first quarter 2026 financial results.--  Successfully resumed sales of American oil from the Santa Ynez Unit in. accordance with the Defense Production Act order from the U.S. Department. --  Reported a net loss of $197.0 million, primarily driven by operating. expenses associated with the resumption of oil transportation through the. Santa Ynez Pipeline System  and the resumption of oil sales,as well as general and administrative expenses, non-cash interest expense. of $34.7 million, and a non-cash loss on the change in fair value of. The information in this press release include \"forward-looking statements\" within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words \"could,\" \"should,\" \"will,\" \"may,\" \"believe,\" \"anticipate,\" \"intend,\" \"estimate,\" \"expect,\" \"project,\" \"continue,\" \"plan,\" \"forecast,\" \"predict,\" \"potential,\" \"future,\" \"outlook,\" and \"target,\" the negative of such terms an","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633181239","title":"Assessing Sable Offshore (SOC) Valuation After Upgraded Earnings Forecasts And Positive Analyst Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2633181239","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633181239?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:29","pubTimestamp":1778063365,"startTime":"0","endTime":"0","summary":"Recent analyst actions around Sable Offshore (SOC), including higher earnings estimates and a favorable research rating, have put the stock on many investors’ radar as they assess potential risk and reward.\nSee our latest analysis for Sable Offshore.\nSOC’s share price is US$14.26, with a 90 day share price return of 72.43% contrasting with a 1 year total shareholder return of 28.20% loss, which suggests improving short term momentum after a weaker year.\nIf this kind of rebound has you...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/energy/nyse-soc/sable-offshore/news/assessing-sable-offshore-soc-valuation-after-upgraded-earnin","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-soc/sable-offshore/news/assessing-sable-offshore-soc-valuation-after-upgraded-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SOC.AU","SOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633677961","title":"New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2633677961","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633677961?lang=en_us&edition=fundamental","pubTime":"2026-05-05 05:00","pubTimestamp":1777928400,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, May  05, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the publication of a new independent analysis of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3287198/0/en/New-Publication-Demonstrates-TLX250-Px-Zircaix-Potential-in-Diagnosing-Kidney-Cancers-Beyond-ccRCC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX","SOC","ASX","BK4543","BK4141","BK4526","BK4213","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632645785","title":"Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2632645785","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632645785?lang=en_us&edition=fundamental","pubTime":"2026-05-02 00:15","pubTimestamp":1777652100,"startTime":"0","endTime":"0","summary":"Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrate significant and consistent improvements in glycemic control in ersodetug treatment arms compared t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/01/3286124/0/en/Rezolute-Announces-Oral-Presentation-of-Results-From-its-Phase-3-sunRIZE-Study-of-Ersodetug-in-Patients-with-Congenital-Hyperinsulinism-at-the-Pediatric-Endocrine-Society-Annual-Me.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPS","LU0128526141.USD","LU2125154778.USD","HI","LU2125154935.USD","LU2360032135.SGD","FAS","BK4213","BK4161","LU0029874061.USD","SOC","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632963645","title":"Sable Offshore Corp call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2632963645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632963645?lang=en_us&edition=fundamental","pubTime":"2026-05-01 23:45","pubTimestamp":1777650316,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Sable Offshore (SOC) Corp with 4,117 calls trading, 1.3x expected, and implied vol increasing over 1 point to 112.6...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sable-offshore-corp-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sable-offshore-corp-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","SOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":197,"code":"91000000","status":"200"}]}}